ERNEST HAWK to Reproducibility of Results
This is a "connection" page, showing publications ERNEST HAWK has written about Reproducibility of Results.
Connection Strength
0.049
-
Biomarkers as surrogates for cancer development. Curr Oncol Rep. 2000 May; 2(3):242-50.
Score: 0.021
-
Correspondence re: E. Hawk, et al., Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the First National Health and Nutrition Examination Survey. Cancer Epidemiol.Biomark. Prev., 9: 523-527, 2000. Cancer Epidemiol Biomarkers Prev. 2001 Apr; 10(4):415-6.
Score: 0.011
-
Translational Research Working Group developmental pathway for biospecimen-based assessment modalities. Clin Cancer Res. 2008 Sep 15; 14(18):5672-7.
Score: 0.010
-
Counterpoint: Because some surrogate end point biomarkers measure the neoplastic process they will have high utility in the development of cancer chemopreventive agents against sporadic cancers. Cancer Epidemiol Biomarkers Prev. 2003 Jul; 12(7):593-6.
Score: 0.007